{"date":"2026-01-27","count":10,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6696-2026-01-27-2103-190uzts","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-01-27","time":"21:03:18","subject":"代重要子公司Belite Bio, Inc公告LBS-008斯特格病變青少年病患之第二/三期臨床試驗收案完成","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-01-27 21:03，「代重要子公司Belite Bio, Inc公告LBS-008斯特格病變青少年病患之第二/三期臨床試驗收案完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6847-2026-01-27-1856-s83qt4","company_id":"6847","company":"普瑞博","market":"興櫃","industry":"生技醫療","date":"2026-01-27","time":"18:56:09","subject":"公告本公司114年現金增資全體董事放棄認購股數達得認購股數二分之一以上，並洽特定人認購事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普瑞博（6847），2026-01-27 18:56，「公告本公司114年現金增資全體董事放棄認購股數達得認購股數二分之一以上，並洽特定人認購事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6847-2026-01-27-1854-11vxjjv","company_id":"6847","company":"普瑞博","market":"興櫃","industry":"生技醫療","date":"2026-01-27","time":"18:54:38","subject":"本公司114年現金增資股款催繳公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普瑞博（6847），2026-01-27 18:54，「本公司114年現金增資股款催繳公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3218-2026-01-27-1749-mr4d0s","company_id":"3218","company":"大學光","market":"上櫃","industry":"生技醫療","date":"2026-01-27","time":"17:49:32","subject":"本公司就臺灣高等法院臺南分院對董事長歐淑芳及處長劉俊杰之宣判結果之說明","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大學光（3218），2026-01-27 17:49，「本公司就臺灣高等法院臺南分院對董事長歐淑芳及處長劉俊杰之宣判結果之說明」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7881-2026-01-27-1649-1vrztj0","company_id":"7881","company":"科明","market":"興櫃","industry":"生技醫療","date":"2026-01-27","time":"16:49:13","subject":"公告本公司董事會決議委任第二屆薪資報酬委員會委員","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：科明（7881），2026-01-27 16:49，「公告本公司董事會決議委任第二屆薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1786-2026-01-27-1622-9ws87k","company_id":"1786","company":"科妍","market":"上市","industry":"生技醫療","date":"2026-01-27","time":"16:22:22","subject":"公告本公司董事會通過第三次買回庫藏股","clause":"第35款","fact_date":"2026-01-27","cite_as":"公開資訊觀測站重大訊息：科妍（1786），2026-01-27 16:22，「公告本公司董事會通過第三次買回庫藏股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6934-2026-01-27-1543-1fry2sp","company_id":"6934","company":"心誠鎂","market":"上市","industry":"生技醫療","date":"2026-01-27","time":"15:43:52","subject":"公告本公司股票初次上市前現金增資員工認購股款催繳事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：心誠鎂（6934），2026-01-27 15:43，「公告本公司股票初次上市前現金增資員工認購股款催繳事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2026-01-27-1542-5rax5d","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-01-27","time":"15:42:05","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-01-27 15:42，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2026-01-27-1541-11b1948","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-01-27","time":"15:41:37","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-01-27 15:41，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2026-01-27-1356-pwkive","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2026-01-27","time":"13:56:37","subject":"代子公司共信醫藥科技股份有限公司公告受邀參加2026年世界馬獸醫協會(WEVA)大會，並發表p-TLS用於治療馬表淺腫瘤之臨床試驗成果","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2026-01-27 13:56，「代子公司共信醫藥科技股份有限公司公告受邀參加2026年世界馬獸醫協會(WEVA)大會，並發表p-TLS用於治療馬表淺腫瘤」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}